Abstract
In this work, we synthesized a new binuclear nitrosyl iron complex of the family of Roussin's red salt ester [Fe2(C8H8NOS)2(NO)4] (complex 1) with 4-acetamidothiophenol (a structural analog of acetaminophen), which generates NO during hydrolysis and is promising for treatment socially significant diseases. It has been established that solvents have a significant effect on the process of its decomposition: in a buffer solution, complex 1 retains its binuclear structure, while in DMSO it forms mononuclear iron-nitrosyl products. Reduced glutathione does not replace 4-acetamidothiophenol ligands in the structure of complex 1. In addition, complex 1 and its products are not coordinated with the known binding sites of bovine serum albumin, including Cys34. It was found that the studied complex 1 is adsorbed on the protein surface due to weak intermolecular interactions, which leads to a decrease in the rate of decomposition, and, as a result, to a longer generation of NO.Thus, it has been shown for the first time that compound 1 and its decay products do not form coordination complexes with the biosubstrates studied in this work. It can be assumed that glutathione will not participate in the transformation of complex 1 in vivo, while albumin, due to the effective stabilization of the complex on the surface, can act as its carrier to therapeutic targets.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call